To further explore the function of human PD1+CXCL13+CD8+T cells in antitumor immunity in vivo, we established HNSCC subcutaneous tumor model by subcutaneously injected HNSCC cell line SAS into NCG mice (Figure 6F). The gene discussed is CXCL13; the disease is head and neck squamous cell carcinoma.